Masthead-Image-Right-min

Navigating Reimbursement for Liquid Biopsy Cancer Testing

Thirty-eight percent of private payers now cover some type of ctDNA-based panel testing. Is your lab aware of evolving payment policies?

Continue Reading...

COVID-19: Insurers Exempt from Covering Workplace Testing

Must Cover “Medically Appropriate” Tests Only

Continue Reading...

12 Tips to Recover Patient Volume and Finances After COVID-19

As patient volumes declined drastically during COVID-19, facilities are eager to get more patients back into the office and provide the care that was delayed.

Continue Reading...

Is Telehealth Here to Stay? Industry Experts say YES!

Predicted to increase over the last decade, it wasn’t until the pandemic that telehealth really began to take off.

Continue Reading...

Healthcare CFOs Looking to Technology Amidst Revenue Decline

The pandemic has required healthcare organizations to take stock of their financial technology.

Continue Reading...